Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Chemomab Therapeutics: Q2 Earnings Insights

  Chemomab Therapeutics (NASDAQ:CMMB) reported its Q2 earnings results on Friday, August 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Chemomab Therapeutics (NASDAQ:CMMB) reported its Q2 earnings results on Friday, August 12, 2022 at 06:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Chemomab Therapeutics missed estimated earnings by 116.0%, reporting an EPS of $-0.54 versus an estimate of $-0.25.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.22 which was followed by a 8.14% increase in the share price the next day.

 

To track all earnings releases for Chemomab Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Arlo Technologies Q1 Earnings

By Benzinga Insights
Today, 3:58 AM
Arlo Technologies (NYSE:ARLO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Arlo Technologies beat estimated earnings by 133.33%, reporting an EPS of $0.01 versus an estimate of $-0.03.

ARLO